10% Discount on Manual & Electric Hospital Beds - Starting from 3 July!

MediGear Ltd

Pentax EB-1970AK

  1. Home
  2. Shop
  3. Medical Diagnostic Equipment
  4. Pentax EB-1970AK
✓ Professional Seller Pentax EB-1970AK
Pentax EB-1970AK
Pentax Medical Diagnostic Equipment

Pentax EB-1970AK

Detect early changes with enhanced airway imaging

The Pentax EB-1970AK is a dedicated video autofluorescence bronchoscope on the SAFE-3000 platform for hospital pulmonology, lung cancer screening services, thoracic oncology centres, and refurbished autofluorescence bronchoscope procurement. With 408 nm laser autofluorescence, dual white-light and AF modes, 2.8 mm therapeutic channel, and 180°/130° angulation, the Pentax EB-1970AK supports early lung cancer detection. Available at Medigear.uk.

Sections
Bronchoscope
Categories
Medical Diagnostic Equipment
Condition
Good
Origin
Germany
Seller Type
Professional Seller
CE & ISO Certified
Global Shipping
Supplier: Medigear
Share: Facebook LinkedIn Twitter Pinterest

The Pentax EB-1970AK is a dedicated video autofluorescence bronchoscope from Pentax, engineered for hospital pulmonology departments, lung cancer screening services, thoracic oncology centres, early bronchial carcinoma detection programmes, surveillance bronchoscopy services, and refurbished autofluorescence bronchoscope procurement. Part of the Pentax K-Series and integrated with the SAFE-3000 video autofluorescence processor, the EB-1970AK forms the first integrated diagnosis and tumour management system for bronchoscopists worldwide today during routine clinical practice in busy daily lung cancer screening settings across hospital networks.

The autofluorescence imaging capability is the defining EB-1970AK function. The SAFE-3000 processor delivers Class 2 laser diode stimulation light at 408 nm wavelength and 20-40 mW power to the bronchial mucosa via the EB-1970AK scope. Normal tissue fluoresces green while abnormal dysplastic or carcinoma in situ tissue shows reduced fluorescence appearing red or brown. The contrast supports early recognition of bronchial carcinoma, dysplasia, and pre-cancerous mucosal change critical for early lung cancer detection across hospital pulmonology services worldwide.

The dual white-light and autofluorescence imaging is another defining EB-1970AK capability. The SAFE-3000 processor combines a 300 W Xenon white light source with the 408 nm Class 2 laser diode autofluorescence stimulation light, supporting both conventional white light bronchoscopy and dedicated AF mode. Combined with the 6.3 mm insertion tube, 2.8 mm therapeutic working channel, 600 mm working length, and 120° field of view, the EB-1970AK supports comprehensive bronchial examination worldwide.

The Pentax EB-1970AK features 180° upward and 130° downward angulation range, ergonomically positioned suction valves and angulation levers, simple one-component valves available in semi-disposable rubber or autoclavable plastic, clear full-screen images, ability to perform conventional diagnostic and therapeutic bronchoscopy alongside autofluorescence imaging, and rich SAFE-3000 connectivity supporting practical procurement across tertiary pulmonology and lung cancer screening services worldwide today during routine practice.

Early Lung Cancer Detection

The Pentax EB-1970AK anchors early lung cancer detection across hospital pulmonology departments, lung cancer screening services, and thoracic oncology centres. The 408 nm laser autofluorescence imaging supports recognition of bronchial carcinoma in situ, dysplasia, and pre-cancerous mucosal changes that may be missed by conventional white-light bronchoscopy across hospital and tertiary referral services worldwide today during routine practice in busy daily screening programmes.

Bronchial Carcinoma Staging

Bronchial carcinoma staging benefits substantially from the EB-1970AK's autofluorescence imaging combined with conventional white light bronchoscopy. The SAFE-3000 integrated diagnosis and tumour management system supports correct staging of bronchial carcinomas — essential for making treatment decisions and estimating survival across hospital thoracic oncology and lung cancer services worldwide today.

Surveillance Bronchoscopy in High-Risk Patients

Surveillance bronchoscopy in high-risk patients benefits substantially from the EB-1970AK's autofluorescence imaging capability. The platform supports surveillance in heavy smokers, patients with chronic obstructive pulmonary disease, post-treatment lung cancer patients, and patients with prior airway dysplasia across hospital pulmonology and surveillance services worldwide today during routine practice.

Diagnostic and Therapeutic Bronchoscopy

Diagnostic and therapeutic bronchoscopy benefit substantially from the EB-1970AK's 2.8 mm therapeutic working channel supporting EndoTherapy accessories including biopsy forceps, snares, and electrocautery probes. Combined with autofluorescence imaging for precise targeting, the platform supports diagnostic biopsy and therapeutic intervention across hospital pulmonology and thoracic services worldwide today.

Bronchial Mucosa Surveillance

Bronchial mucosa surveillance benefits substantially from the EB-1970AK's dual white-light and autofluorescence imaging modes. The platform supports detection of subtle mucosal change, vascular pattern abnormalities, and dysplastic foci across hospital pulmonology, thoracic oncology, and lung cancer multidisciplinary services worldwide today during routine clinical practice in busy daily surveillance settings.

For Hospital Pulmonology and Lung Cancer Services

The Pentax EB-1970AK brings dedicated autofluorescence video bronchoscopy to hospital pulmonology departments, lung cancer screening services, thoracic oncology centres, and tertiary referral programmes through 408 nm laser autofluorescence imaging, dual white-light and AF modes, 2.8 mm therapeutic channel, 180°/130° angulation, SAFE-3000 integrated tumour management, ergonomic valve design, and rich connectivity. Reliable Pentax engineering, SAFE-3000 platform integration, and proven service support meet stringent procurement compliance across institutional services worldwide today during routine practice.

For Lung Cancer Screening Programmes

The EB-1970AK supports early lung cancer detection programmes, surveillance bronchoscopy services, high-risk patient surveillance, and academic medical centres through its dedicated autofluorescence design and SAFE-3000 integrated diagnosis and tumour management. Reliable Pentax engineering and broad clinical applicability support practical integration across hospital lung cancer screening services, thoracic oncology programmes, and surveillance bronchoscopy services worldwide today during busy daily clinical workflows in tertiary settings.

For Medical Equipment Distributors

Pentax is the globally established endoscopy manufacturer with strong brand recognition, comprehensive training resources, expert technical support, and reliable after-sales service networks worldwide. Distributors partnering with Medigear.uk gain access to a complete EB-1970AK ecosystem supported by detailed documentation, warranty coverage, parts availability, and refurbished inventory. Sustained EB-1970AK demand drives consistent distribution value across pulmonology and lung cancer screening channels worldwide today across hospital networks.

408 nm Laser Autofluorescence Imaging

The SAFE-3000 platform delivers Class 2 laser diode stimulation light at 408 nm wavelength and 20-40 mW power. Normal tissue fluoresces green while abnormal tissue shows reduced fluorescence appearing red or brown, supporting early lung cancer detection today.

Dual White-Light and AF Imaging

The EB-1970AK supports both conventional white light bronchoscopy and dedicated autofluorescence mode through the SAFE-3000 processor with 300 W Xenon white light source. The dual imaging modes support standard diagnostic and AF workflows in a single bronchoscope today.

2.8 mm Therapeutic Working Channel

The 2.8 mm therapeutic working channel supports a broad range of EndoTherapy accessories including therapeutic biopsy forceps, snares, and electrocautery probes. The channel enables targeted biopsy of suspicious AF-positive areas across services today.

SAFE-3000 Integrated Tumour Management

The EB-1970AK integrates with the SAFE-3000 Diagnosis and Tumour Management System — the first integrated diagnosis and tumour management system for bronchoscopists. The platform supports early recognition of bronchial carcinomas today.

Powerful 180°/130° Angulation

The EB-1970AK offers 180° upward and 130° downward angulation range supporting comprehensive bronchial access. Combined with the 600 mm working length and 120° field of view, the platform supports detailed examination of bronchi today.

Ergonomic Valve Design

The bronchoscope features ergonomically positioned suction valves and angulation levers optimized for balance and ease of operation. Simple one-component valves offer complete fingertip control of aspiration today.

Rich SAFE-3000 Connectivity

The SAFE-3000 processor provides rich output connectivity including 1x RGBS (BNC), 1x composite (BNC), 2x RGBS (D-sub 9 pin), 2x Y/C, 1x DV, and 3x USB ports — supporting PACS and image management integration today.

The Pentax EB-1970AK autofluorescence bronchoscope is a clinically proven dedicated video autofluorescence platform combining Class 2 laser diode stimulation light at 408 nm wavelength and 20-40 mW power delivered through the integrated SAFE-3000 processor for autofluorescence imaging where normal tissue fluoresces green and abnormal dysplastic or carcinoma in situ tissue shows reduced fluorescence supporting early recognition of bronchial carcinoma, dual white-light and AF imaging modes through 300 W Xenon white light source, 6.3 mm insertion tube outer diameter, 2.8 mm therapeutic working channel, 600 mm working length, 120° field of view, 180° upward and 130° downward angulation, ergonomically positioned suction valves, simple one-component valves in semi-disposable rubber or autoclavable plastic, SAFE-3000 first integrated diagnosis and tumour management system for bronchoscopists, and rich output connectivity in one Pentax K-Series platform. Whether for screening or diagnostic work, the EB-1970AK delivers. Contact Medigear.uk for the EB-1970AK today.

FAQ

Frequently Asked Questions

Everything buyers need to know about sourcing medical equipment through MediGear.

The Pentax EB-1970AK is a dedicated video autofluorescence bronchoscope used for early lung cancer detection, bronchial carcinoma staging, surveillance bronchoscopy in high-risk patients, diagnostic and therapeutic bronchoscopy, and bronchial mucosa surveillance. It serves hospital pulmonology departments, lung cancer screening services, thoracic oncology centres, and refurbished bronchoscope procurement worldwide today.

Autofluorescence imaging is a technique that uses violet/blue laser light at 408 nm wavelength to illuminate the bronchial mucosa. Normal tissue fluoresces green while abnormal dysplastic or carcinoma in situ tissue shows reduced fluorescence appearing red or brown. The contrast supports recognition of pre-cancerous and early cancerous mucosal change that may be missed by conventional white light bronchoscopy.

The SAFE-3000 is the Pentax integrated diagnosis and tumour management system designed specifically for bronchoscopists. The system combines a 300 W Xenon white light source with Class 2 laser diode autofluorescence stimulation light at 408 nm wavelength and 20-40 mW power. The SAFE-3000 supports both conventional white light and dedicated AF imaging in one platform.

The EB-1970AK model designation indicates EB (endoscope/bronchoscope), 1970 (generation/series number), A (Autofluorescence — dedicated AF imaging capability), and K (Pentax K-Series platform). The naming identifies it as the autofluorescence-capable bronchoscope companion to the white-light-only EB-1970K within the Pentax K-Series ecosystem.

The Pentax EB-1970AK features a 6.3 mm insertion tube diameter, 2.8 mm working channel diameter, 600 mm working length, 120° field of view, and 180° upward / 130° downward angulation. The therapeutic-grade dimensions combined with autofluorescence imaging support lung cancer detection and diagnostic biopsy procedures across hospital pulmonology services worldwide today.

Patients who benefit from autofluorescence bronchoscopy include heavy smokers, patients with chronic obstructive pulmonary disease, post-treatment lung cancer patients, patients with prior airway dysplasia, and individuals at high risk of bronchial carcinoma. The technology supports surveillance and early lung cancer detection across hospital pulmonology services worldwide.

The SAFE-3000 platform delivers a Class 2 laser diode stimulation light at 408 nm wavelength with 20 to 40 mW laser power. The 408 nm violet-blue light is the optimal wavelength for inducing tissue autofluorescence, producing strong contrast between normal green-fluorescing tissue and abnormal red-brown reduced-fluorescence dysplastic tissue across hospital pulmonology services worldwide.

Yes. The Pentax EB-1970AK features a 2.8 mm working channel that supports a broad range of EndoTherapy accessories including therapeutic biopsy forceps, snares, and electrocautery probes. The therapeutic-grade channel enables targeted biopsy of AF-positive suspicious areas and supports diagnostic and therapeutic bronchoscopy alongside autofluorescence imaging.

The SAFE-3000 processor provides rich output connectivity including 1x RGBS (BNC), 1x composite (BNC), 2x RGBS (D-sub 9 pin), 2x Y/C, 1x DV, and 3x USB ports. The comprehensive connectivity supports integration with PACS, video recording systems, and reporting platforms across hospital services worldwide today.

The Pentax EB-1970AK is the dedicated autofluorescence (AF) variant of the EB-1970K white-light video bronchoscope. Both share the same K-Series ergonomics, 6.3 mm insertion tube, 2.8 mm therapeutic channel, 180°/130° angulation, and 120° field of view. The EB-1970AK adds dedicated autofluorescence imaging capability when paired with the SAFE-3000 processor.

Medigear.uk supports site planning, installation, commissioning, and clinician training for the Pentax EB-1970AK. Training covers autofluorescence imaging technique, SAFE-3000 platform operation, dual white-light and AF mode workflow, EndoTherapy accessory selection, lung cancer surveillance protocols, and routine maintenance via authorised Pentax service partners worldwide today during routine practice.

Yes. Medigear.uk supports certified refurbished Pentax EB-1970AK procurement at cost-effective prices. Refurbished autofluorescence bronchoscopes undergo comprehensive inspection, AF imaging verification, white light testing, working channel assessment, angulation calibration, SAFE-3000 compatibility verification, image quality verification, and quality control, providing a budget-friendly option for hospital lung cancer services worldwide today.